OXCARBAZEPINE 150 MG TABLET
For 30 tablets
Pharmacies pay
$3.19 filed
30 × $0.10623 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$8.67 estimated
$3.19 + $0.48 (15%) + $5.00 fee per fill = $8.67
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
OXCARBAZEPINE 150 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as oxcarbazepine.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, Camber Pharmaceuticals, Inc. and AvPAK.
FDA’s Established Pharmacologic Class for it is Anti-epileptic Agent.
The NADAC file of 2026-10-14 prices it under 16 NDCs (National Drug Codes); the FDA directory lists 14 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $3.19 for 30 tablets (30 × $0.10623 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Advagen Pharma Limited | 4 | $0.10623 per EA filed |
| Breckenridge Pharmaceutical, Inc. | 4 | $0.10623 per EA filed |
| ANI Pharmaceuticals, Inc. | 1 | $0.10623 per EA filed |
| American Health Packaging | 1 | $0.10623 per EA filed |
| AvPAK | 1 | $0.10623 per EA filed |
| Camber Pharmaceuticals, Inc. | 1 | $0.10623 per EA filed |
| Glenmark Pharmaceuticals Inc., USA | 1 | $0.10623 per EA filed |
| Major Pharmaceuticals | 1 | $0.10623 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.10623 per EA filed |
All 16 NDCs, with labeler and price
- 00904-7262-61 · Major Pharmaceuticals · $0.10623 per EA · eff. 2026-09-23 filed
- 31722-0023-01 · Camber Pharmaceuticals, Inc. · $0.10623 per EA · eff. 2026-09-23 filed
- 50268-0679-11 · not listed as a package in the FDA directory · $0.10623 per EA · eff. 2026-09-23 filed
- 50268-0679-15 · AvPAK · $0.10623 per EA · eff. 2026-09-23 filed
- 51991-0053-01 · Breckenridge Pharmaceutical, Inc. · $0.10623 per EA · eff. 2026-09-23 filed
- 51991-0053-05 · Breckenridge Pharmaceutical, Inc. · $0.10623 per EA · eff. 2026-09-23 filed
- 51991-0292-01 · Breckenridge Pharmaceutical, Inc. · $0.10623 per EA · eff. 2026-09-23 filed
- 51991-0292-05 · Breckenridge Pharmaceutical, Inc. · $0.10623 per EA · eff. 2026-09-23 filed
- 60687-0711-01 · American Health Packaging · $0.10623 per EA · eff. 2026-09-23 filed
- 60687-0711-11 · not listed as a package in the FDA directory · $0.10623 per EA · eff. 2026-09-23 filed
- 62559-0220-01 · ANI Pharmaceuticals, Inc. · $0.10623 per EA · eff. 2026-09-23 filed
- 68462-0137-01 · Glenmark Pharmaceuticals Inc., USA · $0.10623 per EA · eff. 2026-09-23 filed
- 72888-0087-01 · Advagen Pharma Limited · $0.10623 per EA · eff. 2026-09-23 filed
- 72888-0087-05 · Advagen Pharma Limited · $0.10623 per EA · eff. 2026-09-23 filed
- 72888-0462-01 · Advagen Pharma Ltd. · $0.10623 per EA · eff. 2026-09-23 filed
- 72888-0462-02 · Advagen Pharma Ltd. · $0.10623 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
13 other products in the NADAC file share the FDA nonproprietary name oxcarbazepine with OXCARBAZEPINE 150 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| OXCARBAZEPINE 150 MG TABLET this page | $0.10623 per EA filed | We don’t know yet |
| OXCARBAZEPINE 300 MG TABLET | $0.16669 per EA filed | We don’t know yet |
| OXCARBAZEPINE 300 MG/5 ML SUSP | $0.11023 per ML filed | We don’t know yet |
| OXCARBAZEPINE 600 MG TABLET | $0.31696 per EA filed | We don’t know yet |
| OXCARBAZEPINE ER 150 MG TABLET | $3.49768 per EA filed | $12.28128 per EA filed |
| OXCARBAZEPINE ER 300 MG TABLET | $4.73052 per EA filed | $12.28128 per EA filed |
| OXCARBAZEPINE ER 600 MG TABLET | $9.5783 per EA filed | $12.28128 per EA filed |
| OXTELLAR XR 150 MG TABLET | $9.02471 per EA filed | $17.96079 per EA filed |
| OXTELLAR XR 300 MG TABLET | $12.75205 per EA filed | $17.96079 per EA filed |
| OXTELLAR XR 600 MG TABLET | $23.29894 per EA filed | $17.96079 per EA filed |
| TRILEPTAL 150 MG TABLET | $5.72156 per EA filed | We don’t know yet |
| TRILEPTAL 300 MG TABLET | $10.45435 per EA filed | We don’t know yet |
| TRILEPTAL 300 MG/5 ML SUSP | $1.93077 per ML filed | We don’t know yet |
| TRILEPTAL 600 MG TABLET | $19.33273 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-07, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 16 NDCs’ NADAC prices is $0.10623 per EA filed.
Of the 85 other products in FDA’s Anti-epileptic Agent class priced per EA, 69 have a higher middle NADAC price and 16 a lower one. The one in the middle is PHENYTEK 200 MG CAPSULE, at $1.4026 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- GABAPENTIN 600 MG TABLET
- LAMOTRIGINE 100 MG TABLET
- DIVALPROEX SOD ER 250 MG TAB
- PRIMIDONE 125 MG TABLET
- ZONISAMIDE 100 MG CAPSULE